Use of changes in B-type natriuretic peptides to detect ischemia in selected patients

International Journal of Cardiology

Volumn 136, Issue 1, 2009, Pages 40-46

  Staub, Daniel ^a,b   Jauslin, Daniel ^a   Freidank, Heike ^a   Taegtmeyer, Anne ^a   Breidthardt, Tobias ^a   Zellweger, Michael J ^a   Mueller Brand, Jan ^a   Christ, Michael ^a   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Exercise; Ischemia; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TASK PERFORMANCE;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 67649868303     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.024     Document Type: Article

References (33)

1. Davis M., Espiner E., Richards G., et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet 343 (1994) 440-444
2. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
3. Lainchbury J.G., Campbell E., Frampton C.M., Yandle T.G., Nicholls M.G., and Richards A.M. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 42 (2003) 728-735
4. Wright S.P., Doughty R.N., Pearl A., et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol 42 (2003) 1793-1800
5. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
6. Weber M., and Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 92 (2006) 843-849
7. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
8. Jernberg T., Stridsberg M., Venge P., et al. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 40 (2002) 437-445
9. Sadanandan S., Cannon C.P., Chekuri K., et al. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 44 (2004) 564-568
10. Bassan R., Potsch A., Maisel A., et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 26 (2005) 234-240
11. Bibbins-Domingo K., Ansari M., Schiller N.B., et al. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 108 (2003) 2987-2992
12. Weber M., Dill T., Arnold R., et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 148 (2004) 612-620
13. Asada J., Tsuji H., Iwasaka T., et al. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia. Am J Cardiol 93 (2004) 702-704
14. Marumoto K., Hamada M., and Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci 88 (1995) 551-556
15. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 44 (2004) 1988-1995
16. Win H.K., Chang S.M., Raizner M., et al. Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia. Am Heart J 150 (2005) 695-700
17. Staub D., Jonas N., Zellweger M.J., et al. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. Am J Med 118 (2005) 1287. e9-1287. e16
18. Staub D., Nusbaumer C., Zellweger M.J., et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 151 (2006) 1223-1230
19. Zaid G., Tanchilevitch A., Rivlin E., et al. Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with Spect perfusion imaging. Int J Cardiol 117 (2007) 157-164
20. Foote R.S., Pearlman J.D., Siegel A.H., et al. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 44 (2004) 1980-1987
21. Berman D.S., Kiat H., Friedman J.D., et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 22 (1993) 1455-1464
22. Hachamovitch R., Berman D.S., Shaw L.J., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97 (1998) 535-543
23. Mueller T., Gegenhuber A., Poelz W., et al. Preliminary evaluation of the AxSyM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay. Clin Chem 50 (2004) 1104-1106
24. Karl J., Borgya A., Gallusser A., et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest Suppl 230 (1999) 177-181
25. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
26. Rana B.S., Davies J.I., Band M.M., et al. B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes. Heart 92 (2006) 916-920
27. Scharhag J., Herrmann M., Urhausen A., et al. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J 150 (2005) 1128-1134
28. Kaufmann B.A., Pfisterer M.E., Viswanathan S., Muller-Brand J., and Zellweger M.J. Stunning and left ventricular function - how long is the ventricle knocked out? Left ventricular function correlated with ischemic burden and recovery time after stress. Int J Cardiol 112 (2006) 223-228
29. Ramakrishna G., Miller T.D., Hodge D.O., O'Connor M.K., and Gibbons R.J. Differences in left ventricular ejection and volumes measured at rest and poststress by gated sestamibi SPECT. J Nucl Cardiol 13 (2006) 668-674
30. Loong C.Y., and Anagnostopoulos C. Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging. Heart 90 Suppl 5 (2004) v2-v9
31. Lee T.H., and Boucher C.A. Clinical practice. Noninvasive tests in patients with stable coronary artery disease. N Engl J Med 344 (2001) 1840-1845
32. White C.W., Wright C.B., Doty D.B., et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?. N Engl J Med 310 (1984) 819-824
33. Pijls N.H., De Bruyne B., Peels K., et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334 (1996) 1703-1708